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MEDICAID BULLETIN 
 
 
TO:            Providers Indicated 
SUBJECT:  I. Preferred Drug List (PDL) Revisions 
  II. Processing of Claims for Compounded Pharmaceuticals 
  III. Six Month’s Supply for Contraceptives 
 
I. Preferred Drug List (PDL) Revisions 
The following revisions to the preferred drug list (PDL) are effective with dates of service on or after July 
25, 2011.    
Preferred Non-Preferred  
DPP-4 Inhibitors and Combinations 
JANUMET  
JANUVIA  
KOMBIGLYZE XR Changed to Preferred  
ONGLYZA Changed to Preferred  
Proton Pump Inhibitors* 
NEXIUM ACIPHEX 
OMEPRAZOLE DEXILANT 
PANTOPRAZOLE  Changed to Preferred LANSOPRAZOLE** 
 NEXIUM SUSPENSION 
 OMEPRAZOLE / SODIUM BICARB 
 PREVACID 
 PRILOSEC 
 PROTONIX 
 ZEGERID 
* Preferred PPIs will no longer require step therapy/prior authorization. 
** Disintegrating Lansoproazole will continue to be available without PA for patients age 12 and 
under. 
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Non-Ergot Dopamine Agonists 
PRAMIPEXOLE Changed to Preferred MIRAPEX/ MIRAPEX ER 
ROPINIROLE REQUIP/ REQUIP XL 
Antispasmodics (Bladder Relaxants) 
DETROL LA DETROL 
OXYBUTYNIN DITROPAN XL 
OXYTROL ENABLEX Changed to Non-Preferred 
TOVIAZ Changed to Preferred GELNIQUE 
VESICARE TROSPIUM Changed to Non-Preferred 
 SANCTURA XR  
Selective Serotonin Reuptake Inhibitors* 
CITALOPRAM Added as Preferred FLUOXETINE WEEKLY Added as Non-Preferred 
FLUOXETINE Added as Preferred LEXAPRO Added as Non-Preferred 
FLUVOXAMINE Added as Preferred LUVOX CR Added as Non-Preferred 
PAROXETINE Added as Preferred PAROXETINE CR Added as Non-Preferred 
SERTRALINE Added as Preferred PAXIL SUSPENSION Added as Non-Preferred 
 PEXEVA Added as Non-Preferred 
*Patients currently receiving a non-preferred agent will be able to continue without a PA. 
Atypical Antipsychotics* 
CLOZAPINE ABILIFY Changed to Non-Preferred 
FANAPT INVEGA Changed to Non-Preferred 
FAZACLO LATUDA Changed to Non-Preferred 
GEODON SYMBYAX Changed to Non-Preferred 
RISPERIDONE ZYPREXA Changed to Non-Preferred 
SAPHRIS  
SEROQUEL  
SEROQUEL XR  
*Patients currently receiving a non-preferred agent will be able to continue without a PA. 
 
Prescribers are encouraged to write prescriptions for preferred products.  However, if it is determined 
that the patient’s condition requires therapy with a non-preferred drug, the prescriber (or his/her 
designated office personnel) is responsible for initiating the PA request.  A prospective, approved PA 
request will prevent rejection of prescription claims at the pharmacy due to the PA requirement. 
 
PA requests may be submitted online or via telephone or fax to the Magellan Medicaid Administration 
Clinical Call Center.  To access the WebPA tool for online PA submission, visit 
http://southcarolina.fhsc.com, click on "Prescribers", then "WebPA". New users will need to click on 
“UAC” in the right hand corner to request a user id and password.  The toll-free telephone and fax  
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numbers for the Clinical Call Center are 866-247-1181 and 888-603-7696, respectively.  The Magellan 
Clinical Call Center telephone number is reserved for use by healthcare professionals and should not be 
provided to beneficiaries.  Magellan’s Beneficiary Call Center telephone number for Pharmacy Services 
is 800-834-2680. 
 
II. Processing of Claims for Compounded Pharmaceuticals 
 
Effective for claims billed on or after July 25, 2011, pharmacy providers submitting claims for 
compounding pharmacy products may bill for compounding services using the online claims adjudication 
system. 
 
The compounding fee of $50 per hour is paid based on the level of effort of the product compounded.  
The maximum number of minutes to be billed is indicated in the chart below.  For dosage forms not 
included in the chart, pharmacy providers should document actual time spent preparing the compounded 
product, and bill accordingly.  Details regarding the procedure for billing compounding time will be made 
available at http://southcarolina.fhsc.com. 
 
No more than 60 minutes of compounding time will be allowed for any single preparation.  Claims for 
compounds totaling more than $170 in total reimbursement will require prior authorization.   
 
Minutes Type of Product/Dosage Form 
15 
Oral Solutions or Suspensions Involving the Combination of Commercially Available Oral Products 
Topical Preparations Compounded by Combining Commercially Available Topical Products 
Enemas 
30 
Suppositories 
Compounded Capsules 
Topical Preparations Containing Components that are Not Commercially Available in a Topical Formulation 
45 
Oral Liquids Containing Components that are Not Commercially Available in Oral Formulation 
Ophthalmic Preparations 
Chemotherapeutic Topical Agents 
60 Sterile Injectable Preparations 
 
III. Six Month’s Supply for Contraceptives 
Effective with dates of service on or after July 25, 2011, with prescriber’s indication, prescriptions for 
systemic contraceptives may be filled for a six (6) month’s (180-day) supply, rather than the traditional 
31-day supply.    
 
Any questions regarding this bulletin should be directed to the Division of Pharmacy Services at (803) 
898-2876. 
 
 
          
                /S/ 
Anthony E. Keck  
        Director  
